NANOPHARMACEUTICALS AND BIOREMEDIATION

  • Saikh Mahammed Athar Alli

Abstract

Usefulness of nanotechnology is exploring for producing safer and appealing pharmaceuticals. Those devising with said technology has specific surface chemistries and properties, for achieving wished novel physicochemical properties. These being manufactured nanomaterials presented as nanopharmaceuticals bearing dissenting biological and chemical properties comparing their macro form. Comparing natural nanomaterials, manufactured nanomaterials may act differently conferring potential and novel benefits and concurrently may peril. Their dispersion and shading into environment from the composite material may or may not associate with aging and degradation. Major concern bobbing up from their dispersal and shading is fate and ecological consequences and pollution of aquatic system. This may be periling diverse aspects of human life and environment, and causing ecotoxicological effects periling environment and ecology. Diverse remediation process adopting for nullifying ecotoxicological effects of nanomaterials in aquatic system. However, biological systems are receiving attentions for remediating it and process is terming ‘bioremediation’. This process be exploiting to adsorb or sequester pollutants and to remove them. Bioremediation process is considering as novel, improved and efficient methods for degrading and sequestering pollutants of water, seeded nanomaterials. Available literatures are unable to provide insight on nanopharmaceuticals and their bioremediation. In this regard, information collected and presented as a handy reference. This insight features on bioremediation of nanopharmaceuticals and has applicability in nullifying their ecotoxicological effects.

 

KEY WORDS: bioremediation, ecotoxicological, effects, nanomaterials, nanopharmaceuticals, nanotechnology.

Downloads

Download data is not yet available.
Statistics
53 Views | 91 Downloads
How to Cite
Alli, S. M. (2014). NANOPHARMACEUTICALS AND BIOREMEDIATION. Journal of Drug Delivery and Therapeutics, 86-95. https://doi.org/10.22270/jddt.v0i0.886